Principal Scientist - Cancer Vaccines
BioSpace · Englewood, NJ · 1 wk ago
Analyst$165k–$215k/yrFull-time
About the role
Lead ICR's Cancer Prevention Group in researching and developing novel preventive cancer vaccines. Drive end-to-end design, execution and interpretation of preclinical vaccine studies, directly shaping the path to human translation. Collaborate closely with external KOLs and CRO partners to turn cutting-edge cancer immunology insights into first-in-class preventive vaccine programs.
Responsibilities
- Lead research and development of novel preventive cancer vaccines
- Design, execute, and interpret preclinical vaccine studies
- Collaborate with external KOLs and CRO partners
- Derive antigen-specific T cell clones and lines
- Work with molecular T cell receptor repertoire analysis and tracking, T cell proliferation assays, cytokine release assays and ELISPOT
- Experience with vaccine delivery systems, including peptide-, cell- and viral-based systems
- Manage external projects
Requirements
- A PhD, MD or both and at least 10 years of vaccine development experience, preferably cancer vaccines
- In-depth knowledge of and experience researching personalized cancer vaccines, including peptide-based vaccines and neoantigen-based cancer vaccines
- Extensive experience with vaccine epitope identification, selection/prioritization (of neoantigens), vaccine adjuvants and immune response monitoring
- Expertise in cancer stem cell antigens, tumor-associated antigens, neoantigens, immuno-editing and immuno-monitoring
- The ability to work well with CROs
Qualifications
- The ability to work in the United States without sponsorship
- An easygoing, hard-working personality
Skills
- Knowledge of and experience with vaccine epitope identification, selection/prioritization (of neoantigens)
- Experience with molecular T cell receptor repertoire analysis and tracking
- Experience with T cell proliferation assays, cytokine release assays and ELISPOT
- Experience deriving antigen-specific T cell clones and lines
- Expertise in cancer stem cell antigens, tumor-associated antigens, neoantigens, immuno-editing and immuno-monitoring
- Experience with vaccine delivery systems, including peptide-, cell- and viral-based systems
- The ability to work well with CROs and manage external projects
Benefits
- Starting base pay range: $165,000/yr - $215,000/yr
- Starting additional compensation range: $7,500/yr - $20,000/yr
Pay
- Starting base pay range: $165,000/yr - $215,000/yr
Schedule
- Full time